Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Brucella Abortus Vaccine Market Growth 2022-2028

  • LP 4811420
  • 126 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Brucella Abortus Vaccine will have significant change from previous year. According to our (LP Information) latest study, the global Brucella Abortus Vaccine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Brucella Abortus Vaccine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Brucella Abortus Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Brucella Abortus Vaccine market, reaching US$ million by the year 2028. As for the Europe Brucella Abortus Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Brucella Abortus Vaccine players cover Zoetis, CEVA, Merck Animal Health, and Biovet, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Brucella Abortus Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

DNA Vaccines

Subunit Vaccines

Vector Vaccines

B. Abortus Recombinant Mutants

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Cattles

Sheep

Pigs

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Zoetis

CEVA

Merck Animal Health

Biovet

CAVAC

JOVAC

Merial

Colorado Serum Company

VECOL

Tecnovax

Indian Immunologicals

Vetal

Dollvet

Centro Diagnostico Veterinario

Onderstepoort Biological Products

Institute of Animal Health and Veterinary Biologicals

Biogenesis Bago

Instituto Rosenbusch

SYVA Laboratorios

CZ Veterinaria

Hester Biosciences

Qilu Animal Health

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Brucella Abortus Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Brucella Abortus Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Brucella Abortus Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Brucella Abortus Vaccine Segment by Type

2.2.1 DNA Vaccines

2.2.2 Subunit Vaccines

2.2.3 Vector Vaccines

2.2.4 B. Abortus Recombinant Mutants

2.2.5 Others

2.3 Brucella Abortus Vaccine Sales by Type

2.3.1 Global Brucella Abortus Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Brucella Abortus Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Brucella Abortus Vaccine Sale Price by Type (2017-2022)

2.4 Brucella Abortus Vaccine Segment by Application

2.4.1 Cattles

2.4.2 Sheep

2.4.3 Pigs

2.4.4 Others

2.5 Brucella Abortus Vaccine Sales by Application

2.5.1 Global Brucella Abortus Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Brucella Abortus Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Brucella Abortus Vaccine Sale Price by Application (2017-2022)

3 Global Brucella Abortus Vaccine by Company

3.1 Global Brucella Abortus Vaccine Breakdown Data by Company

3.1.1 Global Brucella Abortus Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Brucella Abortus Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Brucella Abortus Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Brucella Abortus Vaccine Revenue by Company (2020-2022)

3.2.2 Global Brucella Abortus Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Brucella Abortus Vaccine Sale Price by Company

3.4 Key Manufacturers Brucella Abortus Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Brucella Abortus Vaccine Product Location Distribution

3.4.2 Players Brucella Abortus Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Brucella Abortus Vaccine by Geographic Region

4.1 World Historic Brucella Abortus Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Brucella Abortus Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Brucella Abortus Vaccine Annual Revenue by Geographic Region

4.2 World Historic Brucella Abortus Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Brucella Abortus Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Brucella Abortus Vaccine Annual Revenue by Country/Region

4.3 Americas Brucella Abortus Vaccine Sales Growth

4.4 APAC Brucella Abortus Vaccine Sales Growth

4.5 Europe Brucella Abortus Vaccine Sales Growth

4.6 Middle East & Africa Brucella Abortus Vaccine Sales Growth

5 Americas

5.1 Americas Brucella Abortus Vaccine Sales by Country

5.1.1 Americas Brucella Abortus Vaccine Sales by Country (2017-2022)

5.1.2 Americas Brucella Abortus Vaccine Revenue by Country (2017-2022)

5.2 Americas Brucella Abortus Vaccine Sales by Type

5.3 Americas Brucella Abortus Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Brucella Abortus Vaccine Sales by Region

6.1.1 APAC Brucella Abortus Vaccine Sales by Region (2017-2022)

6.1.2 APAC Brucella Abortus Vaccine Revenue by Region (2017-2022)

6.2 APAC Brucella Abortus Vaccine Sales by Type

6.3 APAC Brucella Abortus Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Brucella Abortus Vaccine by Country

7.1.1 Europe Brucella Abortus Vaccine Sales by Country (2017-2022)

7.1.2 Europe Brucella Abortus Vaccine Revenue by Country (2017-2022)

7.2 Europe Brucella Abortus Vaccine Sales by Type

7.3 Europe Brucella Abortus Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Brucella Abortus Vaccine by Country

8.1.1 Middle East & Africa Brucella Abortus Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Brucella Abortus Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Brucella Abortus Vaccine Sales by Type

8.3 Middle East & Africa Brucella Abortus Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Brucella Abortus Vaccine

10.3 Manufacturing Process Analysis of Brucella Abortus Vaccine

10.4 Industry Chain Structure of Brucella Abortus Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Brucella Abortus Vaccine Distributors

11.3 Brucella Abortus Vaccine Customer

12 World Forecast Review for Brucella Abortus Vaccine by Geographic Region

12.1 Global Brucella Abortus Vaccine Market Size Forecast by Region

12.1.1 Global Brucella Abortus Vaccine Forecast by Region (2023-2028)

12.1.2 Global Brucella Abortus Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Brucella Abortus Vaccine Forecast by Type

12.7 Global Brucella Abortus Vaccine Forecast by Application

13 Key Players Analysis

13.1 Zoetis

13.1.1 Zoetis Company Information

13.1.2 Zoetis Brucella Abortus Vaccine Product Offered

13.1.3 Zoetis Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Zoetis Main Business Overview

13.1.5 Zoetis Latest Developments

13.2 CEVA

13.2.1 CEVA Company Information

13.2.2 CEVA Brucella Abortus Vaccine Product Offered

13.2.3 CEVA Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 CEVA Main Business Overview

13.2.5 CEVA Latest Developments

13.3 Merck Animal Health

13.3.1 Merck Animal Health Company Information

13.3.2 Merck Animal Health Brucella Abortus Vaccine Product Offered

13.3.3 Merck Animal Health Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Merck Animal Health Main Business Overview

13.3.5 Merck Animal Health Latest Developments

13.4 Biovet

13.4.1 Biovet Company Information

13.4.2 Biovet Brucella Abortus Vaccine Product Offered

13.4.3 Biovet Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Biovet Main Business Overview

13.4.5 Biovet Latest Developments

13.5 CAVAC

13.5.1 CAVAC Company Information

13.5.2 CAVAC Brucella Abortus Vaccine Product Offered

13.5.3 CAVAC Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 CAVAC Main Business Overview

13.5.5 CAVAC Latest Developments

13.6 JOVAC

13.6.1 JOVAC Company Information

13.6.2 JOVAC Brucella Abortus Vaccine Product Offered

13.6.3 JOVAC Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 JOVAC Main Business Overview

13.6.5 JOVAC Latest Developments

13.7 Merial

13.7.1 Merial Company Information

13.7.2 Merial Brucella Abortus Vaccine Product Offered

13.7.3 Merial Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Merial Main Business Overview

13.7.5 Merial Latest Developments

13.8 Colorado Serum Company

13.8.1 Colorado Serum Company Company Information

13.8.2 Colorado Serum Company Brucella Abortus Vaccine Product Offered

13.8.3 Colorado Serum Company Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Colorado Serum Company Main Business Overview

13.8.5 Colorado Serum Company Latest Developments

13.9 VECOL

13.9.1 VECOL Company Information

13.9.2 VECOL Brucella Abortus Vaccine Product Offered

13.9.3 VECOL Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 VECOL Main Business Overview

13.9.5 VECOL Latest Developments

13.10 Tecnovax

13.10.1 Tecnovax Company Information

13.10.2 Tecnovax Brucella Abortus Vaccine Product Offered

13.10.3 Tecnovax Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Tecnovax Main Business Overview

13.10.5 Tecnovax Latest Developments

13.11 Indian Immunologicals

13.11.1 Indian Immunologicals Company Information

13.11.2 Indian Immunologicals Brucella Abortus Vaccine Product Offered

13.11.3 Indian Immunologicals Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Indian Immunologicals Main Business Overview

13.11.5 Indian Immunologicals Latest Developments

13.12 Vetal

13.12.1 Vetal Company Information

13.12.2 Vetal Brucella Abortus Vaccine Product Offered

13.12.3 Vetal Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Vetal Main Business Overview

13.12.5 Vetal Latest Developments

13.13 Dollvet

13.13.1 Dollvet Company Information

13.13.2 Dollvet Brucella Abortus Vaccine Product Offered

13.13.3 Dollvet Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Dollvet Main Business Overview

13.13.5 Dollvet Latest Developments

13.14 Centro Diagnostico Veterinario

13.14.1 Centro Diagnostico Veterinario Company Information

13.14.2 Centro Diagnostico Veterinario Brucella Abortus Vaccine Product Offered

13.14.3 Centro Diagnostico Veterinario Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Centro Diagnostico Veterinario Main Business Overview

13.14.5 Centro Diagnostico Veterinario Latest Developments

13.15 Onderstepoort Biological Products

13.15.1 Onderstepoort Biological Products Company Information

13.15.2 Onderstepoort Biological Products Brucella Abortus Vaccine Product Offered

13.15.3 Onderstepoort Biological Products Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Onderstepoort Biological Products Main Business Overview

13.15.5 Onderstepoort Biological Products Latest Developments

13.16 Institute of Animal Health and Veterinary Biologicals

13.16.1 Institute of Animal Health and Veterinary Biologicals Company Information

13.16.2 Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Product Offered

13.16.3 Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Institute of Animal Health and Veterinary Biologicals Main Business Overview

13.16.5 Institute of Animal Health and Veterinary Biologicals Latest Developments

13.17 Biogenesis Bago

13.17.1 Biogenesis Bago Company Information

13.17.2 Biogenesis Bago Brucella Abortus Vaccine Product Offered

13.17.3 Biogenesis Bago Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Biogenesis Bago Main Business Overview

13.17.5 Biogenesis Bago Latest Developments

13.18 Instituto Rosenbusch

13.18.1 Instituto Rosenbusch Company Information

13.18.2 Instituto Rosenbusch Brucella Abortus Vaccine Product Offered

13.18.3 Instituto Rosenbusch Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Instituto Rosenbusch Main Business Overview

13.18.5 Instituto Rosenbusch Latest Developments

13.19 SYVA Laboratorios

13.19.1 SYVA Laboratorios Company Information

13.19.2 SYVA Laboratorios Brucella Abortus Vaccine Product Offered

13.19.3 SYVA Laboratorios Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 SYVA Laboratorios Main Business Overview

13.19.5 SYVA Laboratorios Latest Developments

13.20 CZ Veterinaria

13.20.1 CZ Veterinaria Company Information

13.20.2 CZ Veterinaria Brucella Abortus Vaccine Product Offered

13.20.3 CZ Veterinaria Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 CZ Veterinaria Main Business Overview

13.20.5 CZ Veterinaria Latest Developments

13.21 Hester Biosciences

13.21.1 Hester Biosciences Company Information

13.21.2 Hester Biosciences Brucella Abortus Vaccine Product Offered

13.21.3 Hester Biosciences Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Hester Biosciences Main Business Overview

13.21.5 Hester Biosciences Latest Developments

13.22 Qilu Animal Health

13.22.1 Qilu Animal Health Company Information

13.22.2 Qilu Animal Health Brucella Abortus Vaccine Product Offered

13.22.3 Qilu Animal Health Brucella Abortus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Qilu Animal Health Main Business Overview

13.22.5 Qilu Animal Health Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Brucella Abortus Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Brucella Abortus Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of DNA Vaccines

Table 4. Major Players of Subunit Vaccines

Table 5. Major Players of Vector Vaccines

Table 6. Major Players of B. Abortus Recombinant Mutants

Table 7. Major Players of Others

Table 8. Global Brucella Abortus Vaccine Sales by Type (2017-2022) & (K Units)

Table 9. Global Brucella Abortus Vaccine Sales Market Share by Type (2017-2022)

Table 10. Global Brucella Abortus Vaccine Revenue by Type (2017-2022) & ($ million)

Table 11. Global Brucella Abortus Vaccine Revenue Market Share by Type (2017-2022)

Table 12. Global Brucella Abortus Vaccine Sale Price by Type (2017-2022) & (USD/Unit)

Table 13. Global Brucella Abortus Vaccine Sales by Application (2017-2022) & (K Units)

Table 14. Global Brucella Abortus Vaccine Sales Market Share by Application (2017-2022)

Table 15. Global Brucella Abortus Vaccine Revenue by Application (2017-2022)

Table 16. Global Brucella Abortus Vaccine Revenue Market Share by Application (2017-2022)

Table 17. Global Brucella Abortus Vaccine Sale Price by Application (2017-2022) & (USD/Unit)

Table 18. Global Brucella Abortus Vaccine Sales by Company (2020-2022) & (K Units)

Table 19. Global Brucella Abortus Vaccine Sales Market Share by Company (2020-2022)

Table 20. Global Brucella Abortus Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Brucella Abortus Vaccine Revenue Market Share by Company (2020-2022)

Table 22. Global Brucella Abortus Vaccine Sale Price by Company (2020-2022) & (USD/Unit)

Table 23. Key Manufacturers Brucella Abortus Vaccine Producing Area Distribution and Sales Area

Table 24. Players Brucella Abortus Vaccine Products Offered

Table 25. Brucella Abortus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Brucella Abortus Vaccine Sales by Geographic Region (2017-2022) & (K Units)

Table 29. Global Brucella Abortus Vaccine Sales Market Share Geographic Region (2017-2022)

Table 30. Global Brucella Abortus Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Brucella Abortus Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Brucella Abortus Vaccine Sales by Country/Region (2017-2022) & (K Units)

Table 33. Global Brucella Abortus Vaccine Sales Market Share by Country/Region (2017-2022)

Table 34. Global Brucella Abortus Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Brucella Abortus Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Brucella Abortus Vaccine Sales by Country (2017-2022) & (K Units)

Table 37. Americas Brucella Abortus Vaccine Sales Market Share by Country (2017-2022)

Table 38. Americas Brucella Abortus Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Brucella Abortus Vaccine Revenue Market Share by Country (2017-2022)

Table 40. Americas Brucella Abortus Vaccine Sales by Type (2017-2022) & (K Units)

Table 41. Americas Brucella Abortus Vaccine Sales Market Share by Type (2017-2022)

Table 42. Americas Brucella Abortus Vaccine Sales by Application (2017-2022) & (K Units)

Table 43. Americas Brucella Abortus Vaccine Sales Market Share by Application (2017-2022)

Table 44. APAC Brucella Abortus Vaccine Sales by Region (2017-2022) & (K Units)

Table 45. APAC Brucella Abortus Vaccine Sales Market Share by Region (2017-2022)

Table 46. APAC Brucella Abortus Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Brucella Abortus Vaccine Revenue Market Share by Region (2017-2022)

Table 48. APAC Brucella Abortus Vaccine Sales by Type (2017-2022) & (K Units)

Table 49. APAC Brucella Abortus Vaccine Sales Market Share by Type (2017-2022)

Table 50. APAC Brucella Abortus Vaccine Sales by Application (2017-2022) & (K Units)

Table 51. APAC Brucella Abortus Vaccine Sales Market Share by Application (2017-2022)

Table 52. Europe Brucella Abortus Vaccine Sales by Country (2017-2022) & (K Units)

Table 53. Europe Brucella Abortus Vaccine Sales Market Share by Country (2017-2022)

Table 54. Europe Brucella Abortus Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Brucella Abortus Vaccine Revenue Market Share by Country (2017-2022)

Table 56. Europe Brucella Abortus Vaccine Sales by Type (2017-2022) & (K Units)

Table 57. Europe Brucella Abortus Vaccine Sales Market Share by Type (2017-2022)

Table 58. Europe Brucella Abortus Vaccine Sales by Application (2017-2022) & (K Units)

Table 59. Europe Brucella Abortus Vaccine Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Brucella Abortus Vaccine Sales by Country (2017-2022) & (K Units)

Table 61. Middle East & Africa Brucella Abortus Vaccine Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Brucella Abortus Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Brucella Abortus Vaccine Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Brucella Abortus Vaccine Sales by Type (2017-2022) & (K Units)

Table 65. Middle East & Africa Brucella Abortus Vaccine Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Brucella Abortus Vaccine Sales by Application (2017-2022) & (K Units)

Table 67. Middle East & Africa Brucella Abortus Vaccine Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Brucella Abortus Vaccine

Table 69. Key Market Challenges & Risks of Brucella Abortus Vaccine

Table 70. Key Industry Trends of Brucella Abortus Vaccine

Table 71. Brucella Abortus Vaccine Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Brucella Abortus Vaccine Distributors List

Table 74. Brucella Abortus Vaccine Customer List

Table 75. Global Brucella Abortus Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 76. Global Brucella Abortus Vaccine Sales Market Forecast by Region

Table 77. Global Brucella Abortus Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Brucella Abortus Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Brucella Abortus Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 80. Americas Brucella Abortus Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Brucella Abortus Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 82. APAC Brucella Abortus Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Brucella Abortus Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Europe Brucella Abortus Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Brucella Abortus Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Middle East & Africa Brucella Abortus Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Brucella Abortus Vaccine Sales Forecast by Type (2023-2028) & (K Units)

Table 88. Global Brucella Abortus Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Brucella Abortus Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Brucella Abortus Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Brucella Abortus Vaccine Sales Forecast by Application (2023-2028) & (K Units)

Table 92. Global Brucella Abortus Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Brucella Abortus Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Brucella Abortus Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 95. Zoetis Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 96. Zoetis Brucella Abortus Vaccine Product Offered

Table 97. Zoetis Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 98. Zoetis Main Business

Table 99. Zoetis Latest Developments

Table 100. CEVA Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 101. CEVA Brucella Abortus Vaccine Product Offered

Table 102. CEVA Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 103. CEVA Main Business

Table 104. CEVA Latest Developments

Table 105. Merck Animal Health Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 106. Merck Animal Health Brucella Abortus Vaccine Product Offered

Table 107. Merck Animal Health Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 108. Merck Animal Health Main Business

Table 109. Merck Animal Health Latest Developments

Table 110. Biovet Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 111. Biovet Brucella Abortus Vaccine Product Offered

Table 112. Biovet Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 113. Biovet Main Business

Table 114. Biovet Latest Developments

Table 115. CAVAC Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 116. CAVAC Brucella Abortus Vaccine Product Offered

Table 117. CAVAC Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 118. CAVAC Main Business

Table 119. CAVAC Latest Developments

Table 120. JOVAC Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 121. JOVAC Brucella Abortus Vaccine Product Offered

Table 122. JOVAC Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 123. JOVAC Main Business

Table 124. JOVAC Latest Developments

Table 125. Merial Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 126. Merial Brucella Abortus Vaccine Product Offered

Table 127. Merial Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 128. Merial Main Business

Table 129. Merial Latest Developments

Table 130. Colorado Serum Company Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 131. Colorado Serum Company Brucella Abortus Vaccine Product Offered

Table 132. Colorado Serum Company Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 133. Colorado Serum Company Main Business

Table 134. Colorado Serum Company Latest Developments

Table 135. VECOL Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 136. VECOL Brucella Abortus Vaccine Product Offered

Table 137. VECOL Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 138. VECOL Main Business

Table 139. VECOL Latest Developments

Table 140. Tecnovax Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 141. Tecnovax Brucella Abortus Vaccine Product Offered

Table 142. Tecnovax Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 143. Tecnovax Main Business

Table 144. Tecnovax Latest Developments

Table 145. Indian Immunologicals Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 146. Indian Immunologicals Brucella Abortus Vaccine Product Offered

Table 147. Indian Immunologicals Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 148. Indian Immunologicals Main Business

Table 149. Indian Immunologicals Latest Developments

Table 150. Vetal Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 151. Vetal Brucella Abortus Vaccine Product Offered

Table 152. Vetal Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 153. Vetal Main Business

Table 154. Vetal Latest Developments

Table 155. Dollvet Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 156. Dollvet Brucella Abortus Vaccine Product Offered

Table 157. Dollvet Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 158. Dollvet Main Business

Table 159. Dollvet Latest Developments

Table 160. Centro Diagnostico Veterinario Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 161. Centro Diagnostico Veterinario Brucella Abortus Vaccine Product Offered

Table 162. Centro Diagnostico Veterinario Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 163. Centro Diagnostico Veterinario Main Business

Table 164. Centro Diagnostico Veterinario Latest Developments

Table 165. Onderstepoort Biological Products Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 166. Onderstepoort Biological Products Brucella Abortus Vaccine Product Offered

Table 167. Onderstepoort Biological Products Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 168. Onderstepoort Biological Products Main Business

Table 169. Onderstepoort Biological Products Latest Developments

Table 170. Institute of Animal Health and Veterinary Biologicals Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 171. Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Product Offered

Table 172. Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 173. Institute of Animal Health and Veterinary Biologicals Main Business

Table 174. Institute of Animal Health and Veterinary Biologicals Latest Developments

Table 175. Biogenesis Bago Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 176. Biogenesis Bago Brucella Abortus Vaccine Product Offered

Table 177. Biogenesis Bago Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 178. Biogenesis Bago Main Business

Table 179. Biogenesis Bago Latest Developments

Table 180. Instituto Rosenbusch Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 181. Instituto Rosenbusch Brucella Abortus Vaccine Product Offered

Table 182. Instituto Rosenbusch Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 183. Instituto Rosenbusch Main Business

Table 184. Instituto Rosenbusch Latest Developments

Table 185. SYVA Laboratorios Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 186. SYVA Laboratorios Brucella Abortus Vaccine Product Offered

Table 187. SYVA Laboratorios Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 188. SYVA Laboratorios Main Business

Table 189. SYVA Laboratorios Latest Developments

Table 190. CZ Veterinaria Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 191. CZ Veterinaria Brucella Abortus Vaccine Product Offered

Table 192. CZ Veterinaria Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 193. CZ Veterinaria Main Business

Table 194. CZ Veterinaria Latest Developments

Table 195. Hester Biosciences Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 196. Hester Biosciences Brucella Abortus Vaccine Product Offered

Table 197. Hester Biosciences Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 198. Hester Biosciences Main Business

Table 199. Hester Biosciences Latest Developments

Table 200. Qilu Animal Health Basic Information, Brucella Abortus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 201. Qilu Animal Health Brucella Abortus Vaccine Product Offered

Table 202. Qilu Animal Health Brucella Abortus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 203. Qilu Animal Health Main Business

Table 204. Qilu Animal Health Latest Developments

List of Figures

Figure 1. Picture of Brucella Abortus Vaccine

Figure 2. Brucella Abortus Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Brucella Abortus Vaccine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Brucella Abortus Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Brucella Abortus Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of DNA Vaccines

Figure 10. Product Picture of Subunit Vaccines

Figure 11. Product Picture of Vector Vaccines

Figure 12. Product Picture of B. Abortus Recombinant Mutants

Figure 13. Product Picture of Others

Figure 14. Global Brucella Abortus Vaccine Sales Market Share by Type in 2021

Figure 15. Global Brucella Abortus Vaccine Revenue Market Share by Type (2017-2022)

Figure 16. Brucella Abortus Vaccine Consumed in Cattles

Figure 17. Global Brucella Abortus Vaccine Market: Cattles (2017-2022) & (K Units)

Figure 18. Brucella Abortus Vaccine Consumed in Sheep

Figure 19. Global Brucella Abortus Vaccine Market: Sheep (2017-2022) & (K Units)

Figure 20. Brucella Abortus Vaccine Consumed in Pigs

Figure 21. Global Brucella Abortus Vaccine Market: Pigs (2017-2022) & (K Units)

Figure 22. Brucella Abortus Vaccine Consumed in Others

Figure 23. Global Brucella Abortus Vaccine Market: Others (2017-2022) & (K Units)

Figure 24. Global Brucella Abortus Vaccine Sales Market Share by Application (2017-2022)

Figure 25. Global Brucella Abortus Vaccine Revenue Market Share by Application in 2021

Figure 26. Brucella Abortus Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Brucella Abortus Vaccine Revenue Market Share by Company in 2021

Figure 28. Global Brucella Abortus Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Brucella Abortus Vaccine Revenue Market Share by Geographic Region in 2021

Figure 30. Global Brucella Abortus Vaccine Sales Market Share by Region (2017-2022)

Figure 31. Global Brucella Abortus Vaccine Revenue Market Share by Country/Region in 2021

Figure 32. Americas Brucella Abortus Vaccine Sales 2017-2022 (K Units)

Figure 33. Americas Brucella Abortus Vaccine Revenue 2017-2022 ($ Millions)

Figure 34. APAC Brucella Abortus Vaccine Sales 2017-2022 (K Units)

Figure 35. APAC Brucella Abortus Vaccine Revenue 2017-2022 ($ Millions)

Figure 36. Europe Brucella Abortus Vaccine Sales 2017-2022 (K Units)

Figure 37. Europe Brucella Abortus Vaccine Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Brucella Abortus Vaccine Sales 2017-2022 (K Units)

Figure 39. Middle East & Africa Brucella Abortus Vaccine Revenue 2017-2022 ($ Millions)

Figure 40. Americas Brucella Abortus Vaccine Sales Market Share by Country in 2021

Figure 41. Americas Brucella Abortus Vaccine Revenue Market Share by Country in 2021

Figure 42. United States Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Brucella Abortus Vaccine Sales Market Share by Region in 2021

Figure 47. APAC Brucella Abortus Vaccine Revenue Market Share by Regions in 2021

Figure 48. China Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Brucella Abortus Vaccine Sales Market Share by Country in 2021

Figure 55. Europe Brucella Abortus Vaccine Revenue Market Share by Country in 2021

Figure 56. Germany Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Brucella Abortus Vaccine Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Brucella Abortus Vaccine Revenue Market Share by Country in 2021

Figure 63. Egypt Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Brucella Abortus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Brucella Abortus Vaccine in 2021

Figure 69. Manufacturing Process Analysis of Brucella Abortus Vaccine

Figure 70. Industry Chain Structure of Brucella Abortus Vaccine

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390